Article
Can zinc enhance response interferon therapy for patients with HCV-related liver disease?
World journal of gastroenterology - 7 Jul 2012
Ishikawa Toru
Abstract excerpt
Patients with liver disease may be at risk of zinc depletion. Zinc supplementation has been shown to contribute to inhibition of liver fibrosis and improvement in hepatic encephalopathy. However, little is known about the anti-inflammatory effect of zinc on hepatitis C virus (HCV)-related chronic liver disease. The standard of care for chronic HCV has improved markedly since the approval of interferon (IFN)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
